13 results
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:17pm
of attrition from the failure of product candidates proceeding through preclinical studies and clinical trials. Positive or timely results from
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:11pm
population than we originally requested.
There is typically an extremely high rate of attrition from the failure of product candidates proceeding through
424B5
q7nqa
8 May 23
Prospectus supplement for primary offering
5:19pm
424B5
rp4c g47ods
8 May 23
Prospectus supplement for primary offering
5:18pm
424B5
dkay aabxb
9 Nov 22
Prospectus supplement for primary offering
4:29pm
10-Q
p66shn
8 Nov 22
Quarterly report
4:09pm
424B5
2zzg9gmp440g14g633
21 Oct 22
Prospectus supplement for primary offering
4:16pm
424B5
eu1kxfax0jv
13 Oct 22
Prospectus supplement for primary offering
4:56pm
- Prev
- 1
- Next